MPL gene mutation is a possible risk factor for thrombosis in patients with essential thrombocythemia in Japan.
Chiho FuruyaYoshinori HashimotoSoji MorishitaTadaaki InanoTomonori OchiaiShuichi ShiraneYoko EdahiroMarito ArakiMiki AndoNorio KomatsuPublished in: Hematology (Amsterdam, Netherlands) (2023)
-mutated ET patients should require more intensive management to prevent recurrence of thrombosis.